Skip to content

Mesoblast Ltd

MESO Nasdaq SEC CIK 1345099

Follow Mesoblast Weekly email: filings, results, news

News

7 stories filed under Mesoblast, grouped into ongoing threads

Call transcript

Thread · 3 stories

Mesoblast Limited (MESO) Q4 2026 Earnings Call Transcript

Earnings 28 d ago

Earnings call transcript: Mesoblast posts $115 million in FY2026 revenue, stock slips

Earnings 29 d ago 2 sources

Mesoblast Limited 2026 Q4 - Results - Earnings Call Presentation

Earnings 43 d ago

More coverage

How Are These Australian Cash Flow Stocks Standing Out?

Tech 28 d ago

Mesoblast FY2026 slides: $115M revenue marks commercial transition

Markets 29 d ago 2 sources

Why is Mesoblast stock surging today?

Markets 38 d ago

Mesoblast stock jumps as phase 3 back pain trial completes

Markets 38 d ago

Profile

Headquarters: MELBOURNE, VICTORIA
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 7 stories clustered from the RSS aggregator